The global Swine Reproductive and Respiratory Syndrome Vaccine market size is predicted to grow from US$ 503 million in 2025 to US$ 921 million in 2031; it is expected to grow at a CAGR of 10.6% from 2025 to 2031.
Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.
Boehringer ingelheim is the company with the largest market share, about 25 percent.
The 鈥淪wine Reproductive and Respiratory Syndrome Vaccine Industry Forecast鈥� looks at past sales and reviews total world Swine Reproductive and Respiratory Syndrome Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Swine Reproductive and Respiratory Syndrome Vaccine sales for 2025 through 2031. With Swine Reproductive and Respiratory Syndrome Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Swine Reproductive and Respiratory Syndrome Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Swine Reproductive and Respiratory Syndrome Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Swine Reproductive and Respiratory Syndrome Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Swine Reproductive and Respiratory Syndrome Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Swine Reproductive and Respiratory Syndrome Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Swine Reproductive and Respiratory Syndrome Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Swine Reproductive and Respiratory Syndrome Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Active Vaccine
Inactivated Vaccines
Segmentation by Application:
Government Tender
麻豆原创 Sales
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
ASCENT CORPORATION
Boehringer-Ingelheim
MSD Animal Health
SPAH
Ceva
Chengdu TECH-BANK Biological Products Co,.Ltd
ringpu
QILU ANIMAL HEALTH PRODUCTS CO.,LTD
DAHUANONG
CAVAC
Komipharm
Agrovet
Bioveta
JINYU BIO-TECNOLOGY CO.,LTD
Phibro Animal Health
ANHUI TIANKANG(GROUP)SHRES O., LTD
Zoetis
WINSUN BIO
PULIKE BIOLOGICAL ENGINERING,INC.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Swine Reproductive and Respiratory Syndrome Vaccine market?
What factors are driving Swine Reproductive and Respiratory Syndrome Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Swine Reproductive and Respiratory Syndrome Vaccine market opportunities vary by end market size?
How does Swine Reproductive and Respiratory Syndrome Vaccine break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Swine Reproductive and Respiratory Syndrome Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Swine Reproductive and Respiratory Syndrome Vaccine Segment by Type
2.2.1 Active Vaccine
2.2.2 Inactivated Vaccines
2.3 Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type
2.3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Price by Type (2020-2025)
2.4 Swine Reproductive and Respiratory Syndrome Vaccine Segment by Application
2.4.1 Government Tender
2.4.2 麻豆原创 Sales
2.5 Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application
2.5.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Breakdown Data by Company
3.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Company (2020-2025)
3.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Price by Company
3.4 Key Manufacturers Swine Reproductive and Respiratory Syndrome Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Swine Reproductive and Respiratory Syndrome Vaccine Product Location Distribution
3.4.2 Players Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Region
4.1 World Historic Swine Reproductive and Respiratory Syndrome Vaccine 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Swine Reproductive and Respiratory Syndrome Vaccine 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth
4.4 APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth
4.5 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth
4.6 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth
5 Americas
5.1 Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country
5.1.1 Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2020-2025)
5.1.2 Americas Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2020-2025)
5.2 Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2020-2025)
5.3 Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region
6.1.1 APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2020-2025)
6.1.2 APAC Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2020-2025)
6.2 APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2020-2025)
6.3 APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine by Country
7.1.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2020-2025)
7.1.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2020-2025)
7.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2020-2025)
7.3 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine by Country
8.1.1 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Swine Reproductive and Respiratory Syndrome Vaccine
10.3 Manufacturing Process Analysis of Swine Reproductive and Respiratory Syndrome Vaccine
10.4 Industry Chain Structure of Swine Reproductive and Respiratory Syndrome Vaccine
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Swine Reproductive and Respiratory Syndrome Vaccine Distributors
11.3 Swine Reproductive and Respiratory Syndrome Vaccine Customer
12 World Forecast Review for Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Region
12.1 Global Swine Reproductive and Respiratory Syndrome Vaccine 麻豆原创 Size Forecast by Region
12.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Forecast by Region (2026-2031)
12.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Swine Reproductive and Respiratory Syndrome Vaccine Forecast by Type (2026-2031)
12.7 Global Swine Reproductive and Respiratory Syndrome Vaccine Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 ASCENT CORPORATION
13.1.1 ASCENT CORPORATION Company Information
13.1.2 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolios and Specifications
13.1.3 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 ASCENT CORPORATION Main Business Overview
13.1.5 ASCENT CORPORATION Latest Developments
13.2 Boehringer-Ingelheim
13.2.1 Boehringer-Ingelheim Company Information
13.2.2 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolios and Specifications
13.2.3 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Boehringer-Ingelheim Main Business Overview
13.2.5 Boehringer-Ingelheim Latest Developments
13.3 MSD Animal Health
13.3.1 MSD Animal Health Company Information
13.3.2 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolios and Specifications
13.3.3 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 MSD Animal Health Main Business Overview
13.3.5 MSD Animal Health Latest Developments
13.4 SPAH
13.4.1 SPAH Company Information
13.4.2 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolios and Specifications
13.4.3 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 SPAH Main Business Overview
13.4.5 SPAH Latest Developments
13.5 Ceva
13.5.1 Ceva Company Information
13.5.2 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolios and Specifications
13.5.3 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Ceva Main Business Overview
13.5.5 Ceva Latest Developments
13.6 Chengdu TECH-BANK Biological Products Co,.Ltd
13.6.1 Chengdu TECH-BANK Biological Products Co,.Ltd Company Information
13.6.2 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolios and Specifications
13.6.3 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Chengdu TECH-BANK Biological Products Co,.Ltd Main Business Overview
13.6.5 Chengdu TECH-BANK Biological Products Co,.Ltd Latest Developments
13.7 ringpu
13.7.1 ringpu Company Information
13.7.2 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolios and Specifications
13.7.3 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 ringpu Main Business Overview
13.7.5 ringpu Latest Developments
13.8 QILU ANIMAL HEALTH PRODUCTS CO.,LTD
13.8.1 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Company Information
13.8.2 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolios and Specifications
13.8.3 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Main Business Overview
13.8.5 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Latest Developments
13.9 DAHUANONG
13.9.1 DAHUANONG Company Information
13.9.2 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolios and Specifications
13.9.3 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 DAHUANONG Main Business Overview
13.9.5 DAHUANONG Latest Developments
13.10 CAVAC
13.10.1 CAVAC Company Information
13.10.2 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolios and Specifications
13.10.3 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 CAVAC Main Business Overview
13.10.5 CAVAC Latest Developments
13.11 Komipharm
13.11.1 Komipharm Company Information
13.11.2 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolios and Specifications
13.11.3 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Komipharm Main Business Overview
13.11.5 Komipharm Latest Developments
13.12 Agrovet
13.12.1 Agrovet Company Information
13.12.2 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolios and Specifications
13.12.3 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Agrovet Main Business Overview
13.12.5 Agrovet Latest Developments
13.13 Bioveta
13.13.1 Bioveta Company Information
13.13.2 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolios and Specifications
13.13.3 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Bioveta Main Business Overview
13.13.5 Bioveta Latest Developments
13.14 JINYU BIO-TECNOLOGY CO.,LTD
13.14.1 JINYU BIO-TECNOLOGY CO.,LTD Company Information
13.14.2 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolios and Specifications
13.14.3 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 JINYU BIO-TECNOLOGY CO.,LTD Main Business Overview
13.14.5 JINYU BIO-TECNOLOGY CO.,LTD Latest Developments
13.15 Phibro Animal Health
13.15.1 Phibro Animal Health Company Information
13.15.2 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolios and Specifications
13.15.3 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Phibro Animal Health Main Business Overview
13.15.5 Phibro Animal Health Latest Developments
13.16 ANHUI TIANKANG(GROUP)SHRES O., LTD
13.16.1 ANHUI TIANKANG(GROUP)SHRES O., LTD Company Information
13.16.2 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolios and Specifications
13.16.3 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 ANHUI TIANKANG(GROUP)SHRES O., LTD Main Business Overview
13.16.5 ANHUI TIANKANG(GROUP)SHRES O., LTD Latest Developments
13.17 Zoetis
13.17.1 Zoetis Company Information
13.17.2 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolios and Specifications
13.17.3 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Zoetis Main Business Overview
13.17.5 Zoetis Latest Developments
13.18 WINSUN BIO
13.18.1 WINSUN BIO Company Information
13.18.2 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolios and Specifications
13.18.3 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 WINSUN BIO Main Business Overview
13.18.5 WINSUN BIO Latest Developments
13.19 PULIKE BIOLOGICAL ENGINERING,INC.
13.19.1 PULIKE BIOLOGICAL ENGINERING,INC. Company Information
13.19.2 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolios and Specifications
13.19.3 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 PULIKE BIOLOGICAL ENGINERING,INC. Main Business Overview
13.19.5 PULIKE BIOLOGICAL ENGINERING,INC. Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
